Capital Impact Advisors, LLC Ionis Pharmaceuticals Inc Transaction History

Capital Impact Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$42.51 - $63.78 $2.71 Million - $4.06 Million	-63,707 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$46.85 - $61.05 $401,036 - $522,588	-8,560 Reduced 11.84%	63,707 $3.76 Million
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $201,094 - $306,475	4,834 Added 7.17%	72,267 $3.42 Million
Q4 2019 Feb 13, 2020	BUY	$53.85 - $65.27 $269,196 - $326,284	4,999 Added 8.01%	67,433 $4.07 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $2.28 Million - $2.78 Million	38,568 Added 161.6%	62,434 $3.69 Million
Q1 2018 Apr 11, 2018	BUY	$44.08 - $55.05 $1.05 Million - $1.31 Million	23,866 New	23,866 $1.05 Million

414

136M

862K

617K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.63B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.